Unimed Pharm passes U.S. FDA’s onsite inspection for disposable artificial tears

A eye drop company Unimed Pharm(CEO Gun-Nam Kim) announced on the 20^th that they successfully passed the U.S. FDA onsite inspection recently for the disposable eye drop ‘Carboxymethylcellulose sodium 0.5%.’

The company said they have shipped a significant amount of the product since their first shipment on April 2017 from Osong Factory, and have been intensively inspected from the U.S. FDA for...